Nuria Fernandez-Hidalgo
Overview
Explore the profile of Nuria Fernandez-Hidalgo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
106
Citations
1596
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lapena P, Urra X, Llopis J, Hernandez-Meneses M, Cuervo G, Maisterra O, et al.
Clin Microbiol Infect
. 2025 Feb;
PMID: 39924109
Objectives: Acute ischaemic strokes (stroke) are frequent and severe extracardiac complications in infective endocarditis (IE). Because intravenous thrombolysis (i.v.-thrombolysis) is contraindicated, mechanical thrombectomy (thrombectomy) offers potential benefits. We aimed to...
2.
Membrillo de Novales F, Falcone M, Soriano A, Fernandez-Hidalgo N, Francisci D, Gentile I, et al.
Int J Antimicrob Agents
. 2025 Jan;
65(4):107450.
PMID: 39864599
Background And Aim: Ceftobiprole, an advanced-generation cephalosporin with broad bactericidal activity, is approved for community-acquired and hospital-acquired pneumonia (excluding ventilator-associated pneumonia). We aimed to evaluate, in a real-world setting, the...
3.
Kirkegaard-Biosca C, Barrio-Tofino E, Villamarin M, Larrosa N, Campany D, Gonzalez-Lopez J, et al.
Antibiotics (Basel)
. 2025 Jan;
14(1.
PMID: 39858394
[...].
4.
Rubinan P, Vinado B, Fernandez-Hidalgo N, Larrosa N, Sempere A, Campany D, et al.
Antibiotics (Basel)
. 2025 Jan;
13(12.
PMID: 39766528
There is no experience with ciprofloxacin for the treatment of carbapenemase-producing Gram-negative bacteria (CP-GNB) infections. This is a retrospective single-centre study where we describe the clinical evolution of all consecutive...
5.
De la Villa S, Escrihuela-Vidal F, Fernandez-Hidalgo N, Escudero-Sanchez R, Cabezon I, Boix-Palop L, et al.
Clin Microbiol Infect
. 2024 Nov;
PMID: 39581546
Objectives: To evaluate the effectiveness of ceftaroline vs. vancomycin or daptomycin in the treatment of methicillin-resistant Staphylococcus aureus bloodstream infections (BSIs) (MRSA-BSIs). Methods: This multicentre retrospective study conducted in 15...
6.
Escrihuela-Vidal F, Fernandez-Hidalgo N, Munoz P, Villamarin M, Jimenez Garcia N, Escudero E, et al.
J Antimicrob Chemother
. 2024 Oct;
79(12):3230-3235.
PMID: 39351977
Background: Infective endocarditis (IE) caused by viridans and gallolyticus group streptococci (VGS-GGS) resistant to penicillin (PEN-R; minimum inhibitory concentration ≥4 mg/L) is rare but poses therapeutic challenges. Objectives: To describe...
7.
Kirkegaard-Biosca C, Barrio-Tofino E, Villamarin M, Larrosa N, Campany D, Gonzalez-Lopez J, et al.
Antibiotics (Basel)
. 2024 Sep;
13(9.
PMID: 39335047
VIM-type-producing Gram-negative bacteria (GNB) infections are difficult to treat. This is a retrospective single-center study of 34 patients who received cefiderocol for the treatment of VIM-type-producing GNB infections, including 25...
8.
Kirkegaard-Biosca C, Moreno-Blas C, Lluch-Alvarez M, Falco-Roget A, Salmeron P, Ramirez-Serra C, et al.
Med Clin (Barc)
. 2024 Aug;
163(10):483-489.
PMID: 39191553
Objective: Central nervous system (CNS) infection poses a diagnostic challenge especially in elderly patients who frequently exhibit atypical symptoms. Our study aimed to identify patients with a low risk of...
9.
Villamarin M, Fernandez-Hidalgo N, Vinado B, Gonzalez-Lopez J, Rello P, Escola-Verge L
J Antimicrob Chemother
. 2024 Aug;
79(11):2809-2814.
PMID: 39158195
Objectives: Clinical experience in the use of teicoplanin for treating enterococcal infective endocarditis (EIE) is scarce. The aim of this study was to describe the characteristics and outcomes of patients...
10.
Tello-Diaz C, Munoz E, Palau M, Gomis X, Gavalda J, Gil-Sala D, et al.
Ann Vasc Surg
. 2024 Jul;
108:475-483.
PMID: 39025221
Background: Biofilm formation is one of the greatest challenges encountered in vascular graft infections. Our aim is to compare the efficacy of 5 antibiotics against methicillin-susceptible Staphylococcus aureus (MSSA) biofilms...